These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20924264)

  • 21. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
    Yanyali A; Nohutcu AF; Horozoglu F; Celik E
    Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial.
    Hoerauf H; Brüggemann A; Muecke M; Lüke J; Müller M; Stefánsson E; Hammes HP; Weiss C
    Graefes Arch Clin Exp Ophthalmol; 2011 Jul; 249(7):997-1008. PubMed ID: 21243370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
    Hartley KL; Smiddy WE; Flynn HW; Murray TG
    Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitrectomy for persistent diffuse diabetic macular edema.
    Stolba U; Binder S; Gruber D; Krebs I; Aggermann T; Neumaier B
    Am J Ophthalmol; 2005 Aug; 140(2):295-301. PubMed ID: 16023067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.
    Bressler SB; Qin H; Beck RW; Chalam KV; Kim JE; Melia M; Wells JA;
    Arch Ophthalmol; 2012 Sep; 130(9):1153-61. PubMed ID: 22965591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitrectomy for Diabetic Macular Edema: Optical Coherence Tomography Criteria and Pathology of the Vitreomacular Interface.
    Hagenau F; Vogt D; Ziada J; Guenther SR; Haritoglou C; Wolf A; Priglinger SG; Schumann RG
    Am J Ophthalmol; 2019 Apr; 200():34-46. PubMed ID: 30557531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EFFECT OF INTERNAL LIMITING MEMBRANE PEELING DURING VITRECTOMY FOR DIABETIC MACULAR EDEMA: Systematic Review and Meta-analysis.
    Nakajima T; Roggia MF; Noda Y; Ueta T
    Retina; 2015 Sep; 35(9):1719-25. PubMed ID: 26079478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. INTERNAL LIMITING MEMBRANE PEELING DURING VITRECTOMY FOR DIABETIC VITREOUS HEMORRHAGE: A Randomized Clinical Trial.
    Rush RB; Del Valle Penella A; Reinauer RM; Rush SW; Bastar PG
    Retina; 2021 May; 41(5):1118-1126. PubMed ID: 32910084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic prediction ability of postoperative multifocal ERG after vitrectomy for diabetic macular edema.
    Leozappa M; Micelli Ferrari T; Grossi T; Pace V; Rinaldi ML; Battista D; Micelli Ferrari L
    Eur J Ophthalmol; 2008; 18(4):609-13. PubMed ID: 18609483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in ciliary body thickness in patients with diabetic macular edema after vitrectomy.
    Kim C; Yu HG
    Retina; 2012 Jul; 32(7):1316-23. PubMed ID: 22466472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
    Yanyali A; Horozoglu F; Celik E; Nohutcu AF
    Retina; 2007 Jun; 27(5):557-66. PubMed ID: 17558316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling.
    Ando F; Yasui O; Hirose H; Ohba N
    Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):995-9. PubMed ID: 15592868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema.
    Kimura T; Kiryu J; Nishiwaki H; Oh H; Suzuma K; Watanabe D; Kurimoto M; Takagi H
    Retina; 2005 Jun; 25(4):454-61. PubMed ID: 15933592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitrectomy for diabetic macular edema: effect of glycemic control (HbA(1c)), renal function (creatinine) and other local factors.
    Kojima T; Terasaki H; Nomura H; Suzuki T; Mori M; Ito Y; Miyake Y
    Ophthalmic Res; 2003; 35(4):192-8. PubMed ID: 12815194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling.
    Yamada Y; Suzuma K; Ryu M; Tsuiki E; Fujikawa A; Kitaoka T
    Curr Eye Res; 2013 Dec; 38(12):1261-5. PubMed ID: 23972000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.
    Pendergast SD; Hassan TS; Williams GA; Cox MS; Margherio RR; Ferrone PJ; Garretson BR; Trese MT
    Am J Ophthalmol; 2000 Aug; 130(2):178-86. PubMed ID: 11004291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema.
    Scott IU; Danis RP; Bressler SB; Bressler NM; Browning DJ; Qin H;
    Retina; 2009 May; 29(5):613-7. PubMed ID: 19373126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema.
    Aiello LP; Edwards AR; Beck RW; Bressler NM; Davis MD; Ferris F; Glassman AR; Ip MS; Miller KM;
    Ophthalmology; 2010 May; 117(5):946-53. PubMed ID: 20122739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.
    Gandorfer A; Messmer EM; Ulbig MW; Kampik A
    Retina; 2000; 20(2):126-33. PubMed ID: 10783944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitrectomy for diabetic macular edema and the relevance of external limiting membrane.
    Ivastinovic D; Haas A; Weger M; Seidel G; Mayer-Xanthaki C; Lindner E; Guttmann A; Wedrich A
    BMC Ophthalmol; 2021 Sep; 21(1):334. PubMed ID: 34525998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.